Exchange: NASDAQ·Updated 11:31 PM EDT
SLS logo

SLS SELLAS Life Sciences Group Inc

$11.43
$0.50
(4.16%)
Today
Closed $11.52
$0.09
(0.78%)
Overnight
EarningsNov 11
Mkt Cap$2.43B
Vol3.89M

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
34

Bearish Sentiment

How do you feel about SLS?

Advertisement|Remove ads.